Xencor, Inc.XNCRNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR+12.1%
5Y CAGR-34.6%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
+12.1%/yr
vs -43.5%/yr prior
5Y CAGR
-34.6%/yr
Recent acceleration
Acceleration
+55.5pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20255.16%
2024-10.22%
202327.08%
20223.67%
202113.37%
202043.18%
201921.63%
201835.85%
201738.36%
201651.94%